Application of local microwave ablation in treatment of breast cancer

doi:10.16139/j.1007-9610.2022.05.005

Abstract

CLC Number:

R737.9

ZHOU Wenbin, TANG Xinyu, WANG Shui. Application of local microwave ablation in treatment of breast cancer[J]. Journal of Surgery Concepts & Practice, 2022, 27(05): 403-405.

References 21

[1]	Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3):209-249.
[2]	Donker M, van Tienhoven G, Straver ME, et al. Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial[J]. Lancet Oncol, 2014, 15(12):1303-1310.
[3]	Petrowsky H, Fritsch R, Guckenberger M, et al. Modern therapeutic approaches for the treatment of malignant liver tumours[J]. Nat Rev Gastroenterol Hepatol, 2020, 17(12):755-772.
[4]	Ahmed M, Brace CL, Lee FT Jr, et al. Principles of and advances in percutaneous ablation[J]. Radiology, 2011, 258(2):351-369.
[5]	Zhou W, Zha X, Liu X, et al. US-guided percutaneous microwave coagulation of small breast cancers: a clinical study[J]. Radiology, 2012, 263(2):364-373.
[6]	Pan H, Qian M, Chen H, et al. Precision breast-conser-ving surgery with microwave ablation guidance: a pilot single-center, prospective cohort study[J]. Front Oncol, 2021, 11:680091.
[7]	Zhou W, Liang M, Pan H, et al. Comparison of ablation zones among different tissues using 2450-MHz cooled-shaft microwave antenna: results in ex vivo porcine mo-dels[J]. PLoS One, 2013, 8(8):e71873.
[8]	Ma G, Chen H, Xu J, et al. Discontinuous moving shot technique for conformal thermal ablation in an ex vivo porcine liver model[J]. Diagn Interv Radiol, 2021, 27(3):418-423.
[9]	Shi X, Pan H, Ge H, et al. Subsequent cooling-circulation after radiofrequency and microwave ablation avoids secondary indirect damage induced by residual thermal energy[J]. Diagn Interv Radiol, 2019, 25(4):291-297.
[10]	Zhou W, Jiang Y, Chen L, et al. Image and pathological changes after microwave ablation of breast cancer: a pilot study[J]. Eur J Radiol, 2014, 83(10):1771-1777.
[11]	Li C, Li C, Ge H, et al. Technical analysis of US imaging for precise microwave ablation for benign breast tumours[J]. Int J Hyperthermia, 2018, 34(8):1179-1185.
[12]	Zhou W, Yu M, Pan H, et al. Microwave ablation induces Th1-type immune response with activation of ICOS pathway in early-stage breast cancer[J]. J Immunother Cancer, 2021, 9(4):e002343.
[13]	Zhou W, Yu M, Mao X, et al. Landscape of the periphe-ral immune response induced by local microwave ablation in patients with breast cancer[J]. Adv Sci (Weinh), 2022, 9(17):e2200033.
[14]	Li L, Wang W, Pan H, et al. Microwave ablation combined with OK-432 induces Th1-type response and specific antitumor immunity in a murine model of breast cancer[J]. J Transl Med, 2017, 15(1):23.
[15]	Zhu J, Yu M, Chen L, et al. Enhanced antitumor efficacy through microwave ablation in combination with immune checkpoints blockade in breast cancer: a pre-clinical study in a murine model[J]. Diagn Interv Imaging, 2018, 99(3):135-142.
[16]	Schumacher TN, Schreiber RD. Neoantigens in cancer immunotherapy[J]. Science, 2015, 348(6230):69-74.
[17]	Mcarthur HL, Diab A, Page DB, et al. A pilot study of preoperative single-dose ipilimumab and/or cryoablation in women with early-stage breast cancer with comprehensive immune profiling[J]. Clin Cancer Res, 2016, 22(23):5729-5737.
[18]	Ho AY, Barker CA, Arnold BB, et al. A phase 2 clinical trial assessing the efficacy and safety of pembrolizumab and radiotherapy in patients with metastatic triple-negative breast cancer[J]. Cancer, 2020, 126(4):850-860.
[19]	Voorwerk L, Slagter M, Horlings HM, et al. Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial[J]. Nat Med, 2019, 25(6):920-928.
[20]	Schmid P, Rugo HS, Adams S, et al. Atezolizumab plus nab-paclitaxel as first-line treatment for unresectable, locally advanced or metastatic triple-negative breast cancer (IMpassion130): updated efficacy results from a randomised, double-blind, placebo-controlled, phase 3 trial[J]. Lancet Oncol, 2020, 21(1):44-59.
[21]	Yu M, Pan H, Che N, et al. Microwave ablation of primary breast cancer inhibits metastatic progression in model mice via activation of natural killer cells[J]. Cell Mol Immunol, 2021, 18(9):2153-2164.

Application of local microwave ablation in treatment of breast cancer

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References 21

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	ZHU Qiaoli, MIAO Yiming, CHEN Xiaosong. Prognostic analysis of breast-conserving surgery or mastectomy in patients with stage Ⅰ-Ⅲ triple-negative breast cancer [J]. Journal of Surgery Concepts & Practice, 2023, 28(04): 371-377.
[2]	YANG Yi, YANG Xingxia, JIN Sili, ZHANG Xu, ZHU Juanying, CHEN Xiaosong. Clinical application of preoperative MRI examination in breast-conserving surgery for ductal carcinoma in situ [J]. Journal of Surgery Concepts & Practice, 2023, 28(04): 378-382.
[3]	DONG Jun, CUI Fengming, LIU Jun. Effects of silencing Ki-67 gene on doxorubicin resistance of breast cancer MCF-7/DOX cells [J]. Journal of Surgery Concepts & Practice, 2023, 28(03): 254-259.
[4]	GAO Weiqi, ZHANG Xu, WANG Zheng, ZHU Yifei, HUANG Jiahui, HONG Jin, ZHU Siji, CHEN Xiaosong, HUANG Ou, HE Jianrong, CHEN Weiguo, LI Yafen, SHEN Kunwei, XU Hua, WU Jiayi. Safety analysis of immediate breast reconstruction with deep inferior epigastric perforator after neoadjuvant treatment [J]. Journal of Surgery Concepts & Practice, 2023, 28(02): 147-151.
[5]	XIE Yanyan, LU Qing, DU Zhenggui. Endoscopic and robotic breast surgery: present and future—the experience of West China Hospital [J]. Journal of Surgery Concepts & Practice, 2022, 27(05): 396-402.
[6]	CHEN Yiding, WU Shijie. Surgical treatment of hereditary breast cancer [J]. Journal of Surgery Concepts & Practice, 2022, 27(05): 392-395.
[7]	WU Jiayi, LU Yujie, HE Jinguang, SHEN Kunwei, XU Hua. Post-mastectomy implant-based breast reconstruction [J]. Journal of Surgery Concepts & Practice, 2022, 27(05): 387-391.
[8]	CHEN Xiaosong, SHEN Kunwei, Ll Hongwei. Diagnosis and treatment in early operable breast cancer: current status and prospect [J]. Journal of Surgery Concepts & Practice, 2022, 27(05): 385-386.
[9]	. [J]. Journal of Surgery Concepts & Practice, 2022, 27(05): 406-410.
[10]	. [J]. Journal of Surgery Concepts & Practice, 2022, 27(05): 411-415.
[11]	. [J]. Journal of Surgery Concepts & Practice, 2022, 27(05): 416-420.
[12]	YANG Cuiyan, WANG Haoyu, CHEN Xiaosong, SHEN Kunwei. Study on tumour suppressor gene TP53 mutation and prognosis in patients with triple-negative breast cancer [J]. Journal of Surgery Concepts & Practice, 2022, 27(05): 421-428.
[13]	PAN Ruixin, CHEN Xiaosong, SHEN Kunwei. Study on circulating tumor DNA and circulating tumor cell detecting minimal residual disease in breast cancer [J]. Journal of Surgery Concepts & Practice, 2022, 27(05): 463-467.
[14]	ZHU Siyi, CHEN Xiaosong, SHEN Kunwei. Study on obesity associated with prognosis of early breast cancer and efficacy of adjuvant therapy [J]. Journal of Surgery Concepts & Practice, 2022, 27(05): 468-472.
[15]	WANG Jieqiang, MA Dekui. Study on trophoblast cell-surface antigen 2 gene and triple-negative breast cancer [J]. Journal of Surgery Concepts & Practice, 2022, 27(05): 473-477.